Global New Psychoactive Substance Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global New Psychoactive Substance market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global New Psychoactive Substance Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the New Psychoactive Substance market in any manner.
Global New Psychoactive Substance Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies
Market Segmentation (by Type)
Stimulants
Cannabinoids
Hallucinogens
Depressants
Market Segmentation (by Application)
Cancer
Neuropathic Disorders
Spasticity
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the New Psychoactive Substance Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global New Psychoactive Substance market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global New Psychoactive Substance Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the New Psychoactive Substance market in any manner.
Global New Psychoactive Substance Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies
Market Segmentation (by Type)
Stimulants
Cannabinoids
Hallucinogens
Depressants
Market Segmentation (by Application)
Cancer
Neuropathic Disorders
Spasticity
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the New Psychoactive Substance Market
- Overview of the regional outlook of the New Psychoactive Substance Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the New Psychoactive Substance Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of New Psychoactive Substance
1.2 Key Market Segments
1.2.1 New Psychoactive Substance Segment by Type
1.2.2 New Psychoactive Substance Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEW PSYCHOACTIVE SUBSTANCE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global New Psychoactive Substance Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global New Psychoactive Substance Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEW PSYCHOACTIVE SUBSTANCE MARKET COMPETITIVE LANDSCAPE
3.1 Global New Psychoactive Substance Sales by Manufacturers (2019-2024)
3.2 Global New Psychoactive Substance Revenue Market Share by Manufacturers (2019-2024)
3.3 New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global New Psychoactive Substance Average Price by Manufacturers (2019-2024)
3.5 Manufacturers New Psychoactive Substance Sales Sites, Area Served, Product Type
3.6 New Psychoactive Substance Market Competitive Situation and Trends
3.6.1 New Psychoactive Substance Market Concentration Rate
3.6.2 Global 5 and 10 Largest New Psychoactive Substance Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEW PSYCHOACTIVE SUBSTANCE INDUSTRY CHAIN ANALYSIS
4.1 New Psychoactive Substance Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEW PSYCHOACTIVE SUBSTANCE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEW PSYCHOACTIVE SUBSTANCE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global New Psychoactive Substance Sales Market Share by Type (2019-2024)
6.3 Global New Psychoactive Substance Market Size Market Share by Type (2019-2024)
6.4 Global New Psychoactive Substance Price by Type (2019-2024)
7 NEW PSYCHOACTIVE SUBSTANCE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global New Psychoactive Substance Market Sales by Application (2019-2024)
7.3 Global New Psychoactive Substance Market Size (M USD) by Application (2019-2024)
7.4 Global New Psychoactive Substance Sales Growth Rate by Application (2019-2024)
8 NEW PSYCHOACTIVE SUBSTANCE MARKET SEGMENTATION BY REGION
8.1 Global New Psychoactive Substance Sales by Region
8.1.1 Global New Psychoactive Substance Sales by Region
8.1.2 Global New Psychoactive Substance Sales Market Share by Region
8.2 North America
8.2.1 North America New Psychoactive Substance Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe New Psychoactive Substance Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific New Psychoactive Substance Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America New Psychoactive Substance Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa New Psychoactive Substance Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Zynerba Pharmaceuticals
9.1.1 Zynerba Pharmaceuticals New Psychoactive Substance Basic Information
9.1.2 Zynerba Pharmaceuticals New Psychoactive Substance Product Overview
9.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Product Market Performance
9.1.4 Zynerba Pharmaceuticals Business Overview
9.1.5 Zynerba Pharmaceuticals New Psychoactive Substance SWOT Analysis
9.1.6 Zynerba Pharmaceuticals Recent Developments
9.2 GW Pharmaceuticals
9.2.1 GW Pharmaceuticals New Psychoactive Substance Basic Information
9.2.2 GW Pharmaceuticals New Psychoactive Substance Product Overview
9.2.3 GW Pharmaceuticals New Psychoactive Substance Product Market Performance
9.2.4 GW Pharmaceuticals Business Overview
9.2.5 GW Pharmaceuticals New Psychoactive Substance SWOT Analysis
9.2.6 GW Pharmaceuticals Recent Developments
9.3 Teewinot Life Sciences
9.3.1 Teewinot Life Sciences New Psychoactive Substance Basic Information
9.3.2 Teewinot Life Sciences New Psychoactive Substance Product Overview
9.3.3 Teewinot Life Sciences New Psychoactive Substance Product Market Performance
9.3.4 Teewinot Life Sciences New Psychoactive Substance SWOT Analysis
9.3.5 Teewinot Life Sciences Business Overview
9.3.6 Teewinot Life Sciences Recent Developments
9.4 AusCann
9.4.1 AusCann New Psychoactive Substance Basic Information
9.4.2 AusCann New Psychoactive Substance Product Overview
9.4.3 AusCann New Psychoactive Substance Product Market Performance
9.4.4 AusCann Business Overview
9.4.5 AusCann Recent Developments
9.5 Cannabics Pharmaceuticals
9.5.1 Cannabics Pharmaceuticals New Psychoactive Substance Basic Information
9.5.2 Cannabics Pharmaceuticals New Psychoactive Substance Product Overview
9.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Product Market Performance
9.5.4 Cannabics Pharmaceuticals Business Overview
9.5.5 Cannabics Pharmaceuticals Recent Developments
9.6 Tilray
9.6.1 Tilray New Psychoactive Substance Basic Information
9.6.2 Tilray New Psychoactive Substance Product Overview
9.6.3 Tilray New Psychoactive Substance Product Market Performance
9.6.4 Tilray Business Overview
9.6.5 Tilray Recent Developments
9.7 Cyrelian
9.7.1 Cyrelian New Psychoactive Substance Basic Information
9.7.2 Cyrelian New Psychoactive Substance Product Overview
9.7.3 Cyrelian New Psychoactive Substance Product Market Performance
9.7.4 Cyrelian Business Overview
9.7.5 Cyrelian Recent Developments
9.8 Anandia Laboratories
9.8.1 Anandia Laboratories New Psychoactive Substance Basic Information
9.8.2 Anandia Laboratories New Psychoactive Substance Product Overview
9.8.3 Anandia Laboratories New Psychoactive Substance Product Market Performance
9.8.4 Anandia Laboratories Business Overview
9.8.5 Anandia Laboratories Recent Developments
9.9 InMed Pharmaceuticals
9.9.1 InMed Pharmaceuticals New Psychoactive Substance Basic Information
9.9.2 InMed Pharmaceuticals New Psychoactive Substance Product Overview
9.9.3 InMed Pharmaceuticals New Psychoactive Substance Product Market Performance
9.9.4 InMed Pharmaceuticals Business Overview
9.9.5 InMed Pharmaceuticals Recent Developments
9.10 Renew Biopharma
9.10.1 Renew Biopharma New Psychoactive Substance Basic Information
9.10.2 Renew Biopharma New Psychoactive Substance Product Overview
9.10.3 Renew Biopharma New Psychoactive Substance Product Market Performance
9.10.4 Renew Biopharma Business Overview
9.10.5 Renew Biopharma Recent Developments
9.11 Cronos Group
9.11.1 Cronos Group New Psychoactive Substance Basic Information
9.11.2 Cronos Group New Psychoactive Substance Product Overview
9.11.3 Cronos Group New Psychoactive Substance Product Market Performance
9.11.4 Cronos Group Business Overview
9.11.5 Cronos Group Recent Developments
9.12 ICC International Cannabis
9.12.1 ICC International Cannabis New Psychoactive Substance Basic Information
9.12.2 ICC International Cannabis New Psychoactive Substance Product Overview
9.12.3 ICC International Cannabis New Psychoactive Substance Product Market Performance
9.12.4 ICC International Cannabis Business Overview
9.12.5 ICC International Cannabis Recent Developments
9.13 Biotii Technologies
9.13.1 Biotii Technologies New Psychoactive Substance Basic Information
9.13.2 Biotii Technologies New Psychoactive Substance Product Overview
9.13.3 Biotii Technologies New Psychoactive Substance Product Market Performance
9.13.4 Biotii Technologies Business Overview
9.13.5 Biotii Technologies Recent Developments
10 NEW PSYCHOACTIVE SUBSTANCE MARKET FORECAST BY REGION
10.1 Global New Psychoactive Substance Market Size Forecast
10.2 Global New Psychoactive Substance Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe New Psychoactive Substance Market Size Forecast by Country
10.2.3 Asia Pacific New Psychoactive Substance Market Size Forecast by Region
10.2.4 South America New Psychoactive Substance Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of New Psychoactive Substance by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global New Psychoactive Substance Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of New Psychoactive Substance by Type (2025-2030)
11.1.2 Global New Psychoactive Substance Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of New Psychoactive Substance by Type (2025-2030)
11.2 Global New Psychoactive Substance Market Forecast by Application (2025-2030)
11.2.1 Global New Psychoactive Substance Sales (K Units) Forecast by Application
11.2.2 Global New Psychoactive Substance Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of New Psychoactive Substance
1.2 Key Market Segments
1.2.1 New Psychoactive Substance Segment by Type
1.2.2 New Psychoactive Substance Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEW PSYCHOACTIVE SUBSTANCE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global New Psychoactive Substance Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global New Psychoactive Substance Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEW PSYCHOACTIVE SUBSTANCE MARKET COMPETITIVE LANDSCAPE
3.1 Global New Psychoactive Substance Sales by Manufacturers (2019-2024)
3.2 Global New Psychoactive Substance Revenue Market Share by Manufacturers (2019-2024)
3.3 New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global New Psychoactive Substance Average Price by Manufacturers (2019-2024)
3.5 Manufacturers New Psychoactive Substance Sales Sites, Area Served, Product Type
3.6 New Psychoactive Substance Market Competitive Situation and Trends
3.6.1 New Psychoactive Substance Market Concentration Rate
3.6.2 Global 5 and 10 Largest New Psychoactive Substance Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEW PSYCHOACTIVE SUBSTANCE INDUSTRY CHAIN ANALYSIS
4.1 New Psychoactive Substance Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEW PSYCHOACTIVE SUBSTANCE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEW PSYCHOACTIVE SUBSTANCE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global New Psychoactive Substance Sales Market Share by Type (2019-2024)
6.3 Global New Psychoactive Substance Market Size Market Share by Type (2019-2024)
6.4 Global New Psychoactive Substance Price by Type (2019-2024)
7 NEW PSYCHOACTIVE SUBSTANCE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global New Psychoactive Substance Market Sales by Application (2019-2024)
7.3 Global New Psychoactive Substance Market Size (M USD) by Application (2019-2024)
7.4 Global New Psychoactive Substance Sales Growth Rate by Application (2019-2024)
8 NEW PSYCHOACTIVE SUBSTANCE MARKET SEGMENTATION BY REGION
8.1 Global New Psychoactive Substance Sales by Region
8.1.1 Global New Psychoactive Substance Sales by Region
8.1.2 Global New Psychoactive Substance Sales Market Share by Region
8.2 North America
8.2.1 North America New Psychoactive Substance Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe New Psychoactive Substance Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific New Psychoactive Substance Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America New Psychoactive Substance Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa New Psychoactive Substance Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Zynerba Pharmaceuticals
9.1.1 Zynerba Pharmaceuticals New Psychoactive Substance Basic Information
9.1.2 Zynerba Pharmaceuticals New Psychoactive Substance Product Overview
9.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Product Market Performance
9.1.4 Zynerba Pharmaceuticals Business Overview
9.1.5 Zynerba Pharmaceuticals New Psychoactive Substance SWOT Analysis
9.1.6 Zynerba Pharmaceuticals Recent Developments
9.2 GW Pharmaceuticals
9.2.1 GW Pharmaceuticals New Psychoactive Substance Basic Information
9.2.2 GW Pharmaceuticals New Psychoactive Substance Product Overview
9.2.3 GW Pharmaceuticals New Psychoactive Substance Product Market Performance
9.2.4 GW Pharmaceuticals Business Overview
9.2.5 GW Pharmaceuticals New Psychoactive Substance SWOT Analysis
9.2.6 GW Pharmaceuticals Recent Developments
9.3 Teewinot Life Sciences
9.3.1 Teewinot Life Sciences New Psychoactive Substance Basic Information
9.3.2 Teewinot Life Sciences New Psychoactive Substance Product Overview
9.3.3 Teewinot Life Sciences New Psychoactive Substance Product Market Performance
9.3.4 Teewinot Life Sciences New Psychoactive Substance SWOT Analysis
9.3.5 Teewinot Life Sciences Business Overview
9.3.6 Teewinot Life Sciences Recent Developments
9.4 AusCann
9.4.1 AusCann New Psychoactive Substance Basic Information
9.4.2 AusCann New Psychoactive Substance Product Overview
9.4.3 AusCann New Psychoactive Substance Product Market Performance
9.4.4 AusCann Business Overview
9.4.5 AusCann Recent Developments
9.5 Cannabics Pharmaceuticals
9.5.1 Cannabics Pharmaceuticals New Psychoactive Substance Basic Information
9.5.2 Cannabics Pharmaceuticals New Psychoactive Substance Product Overview
9.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Product Market Performance
9.5.4 Cannabics Pharmaceuticals Business Overview
9.5.5 Cannabics Pharmaceuticals Recent Developments
9.6 Tilray
9.6.1 Tilray New Psychoactive Substance Basic Information
9.6.2 Tilray New Psychoactive Substance Product Overview
9.6.3 Tilray New Psychoactive Substance Product Market Performance
9.6.4 Tilray Business Overview
9.6.5 Tilray Recent Developments
9.7 Cyrelian
9.7.1 Cyrelian New Psychoactive Substance Basic Information
9.7.2 Cyrelian New Psychoactive Substance Product Overview
9.7.3 Cyrelian New Psychoactive Substance Product Market Performance
9.7.4 Cyrelian Business Overview
9.7.5 Cyrelian Recent Developments
9.8 Anandia Laboratories
9.8.1 Anandia Laboratories New Psychoactive Substance Basic Information
9.8.2 Anandia Laboratories New Psychoactive Substance Product Overview
9.8.3 Anandia Laboratories New Psychoactive Substance Product Market Performance
9.8.4 Anandia Laboratories Business Overview
9.8.5 Anandia Laboratories Recent Developments
9.9 InMed Pharmaceuticals
9.9.1 InMed Pharmaceuticals New Psychoactive Substance Basic Information
9.9.2 InMed Pharmaceuticals New Psychoactive Substance Product Overview
9.9.3 InMed Pharmaceuticals New Psychoactive Substance Product Market Performance
9.9.4 InMed Pharmaceuticals Business Overview
9.9.5 InMed Pharmaceuticals Recent Developments
9.10 Renew Biopharma
9.10.1 Renew Biopharma New Psychoactive Substance Basic Information
9.10.2 Renew Biopharma New Psychoactive Substance Product Overview
9.10.3 Renew Biopharma New Psychoactive Substance Product Market Performance
9.10.4 Renew Biopharma Business Overview
9.10.5 Renew Biopharma Recent Developments
9.11 Cronos Group
9.11.1 Cronos Group New Psychoactive Substance Basic Information
9.11.2 Cronos Group New Psychoactive Substance Product Overview
9.11.3 Cronos Group New Psychoactive Substance Product Market Performance
9.11.4 Cronos Group Business Overview
9.11.5 Cronos Group Recent Developments
9.12 ICC International Cannabis
9.12.1 ICC International Cannabis New Psychoactive Substance Basic Information
9.12.2 ICC International Cannabis New Psychoactive Substance Product Overview
9.12.3 ICC International Cannabis New Psychoactive Substance Product Market Performance
9.12.4 ICC International Cannabis Business Overview
9.12.5 ICC International Cannabis Recent Developments
9.13 Biotii Technologies
9.13.1 Biotii Technologies New Psychoactive Substance Basic Information
9.13.2 Biotii Technologies New Psychoactive Substance Product Overview
9.13.3 Biotii Technologies New Psychoactive Substance Product Market Performance
9.13.4 Biotii Technologies Business Overview
9.13.5 Biotii Technologies Recent Developments
10 NEW PSYCHOACTIVE SUBSTANCE MARKET FORECAST BY REGION
10.1 Global New Psychoactive Substance Market Size Forecast
10.2 Global New Psychoactive Substance Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe New Psychoactive Substance Market Size Forecast by Country
10.2.3 Asia Pacific New Psychoactive Substance Market Size Forecast by Region
10.2.4 South America New Psychoactive Substance Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of New Psychoactive Substance by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global New Psychoactive Substance Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of New Psychoactive Substance by Type (2025-2030)
11.1.2 Global New Psychoactive Substance Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of New Psychoactive Substance by Type (2025-2030)
11.2 Global New Psychoactive Substance Market Forecast by Application (2025-2030)
11.2.1 Global New Psychoactive Substance Sales (K Units) Forecast by Application
11.2.2 Global New Psychoactive Substance Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. New Psychoactive Substance Market Size Comparison by Region (M USD)
Table 5. Global New Psychoactive Substance Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global New Psychoactive Substance Sales Market Share by Manufacturers (2019-2024)
Table 7. Global New Psychoactive Substance Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global New Psychoactive Substance Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2022)
Table 10. Global Market New Psychoactive Substance Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers New Psychoactive Substance Sales Sites and Area Served
Table 12. Manufacturers New Psychoactive Substance Product Type
Table 13. Global New Psychoactive Substance Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of New Psychoactive Substance
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. New Psychoactive Substance Market Challenges
Table 22. Global New Psychoactive Substance Sales by Type (K Units)
Table 23. Global New Psychoactive Substance Market Size by Type (M USD)
Table 24. Global New Psychoactive Substance Sales (K Units) by Type (2019-2024)
Table 25. Global New Psychoactive Substance Sales Market Share by Type (2019-2024)
Table 26. Global New Psychoactive Substance Market Size (M USD) by Type (2019-2024)
Table 27. Global New Psychoactive Substance Market Size Share by Type (2019-2024)
Table 28. Global New Psychoactive Substance Price (USD/Unit) by Type (2019-2024)
Table 29. Global New Psychoactive Substance Sales (K Units) by Application
Table 30. Global New Psychoactive Substance Market Size by Application
Table 31. Global New Psychoactive Substance Sales by Application (2019-2024) & (K Units)
Table 32. Global New Psychoactive Substance Sales Market Share by Application (2019-2024)
Table 33. Global New Psychoactive Substance Sales by Application (2019-2024) & (M USD)
Table 34. Global New Psychoactive Substance Market Share by Application (2019-2024)
Table 35. Global New Psychoactive Substance Sales Growth Rate by Application (2019-2024)
Table 36. Global New Psychoactive Substance Sales by Region (2019-2024) & (K Units)
Table 37. Global New Psychoactive Substance Sales Market Share by Region (2019-2024)
Table 38. North America New Psychoactive Substance Sales by Country (2019-2024) & (K Units)
Table 39. Europe New Psychoactive Substance Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific New Psychoactive Substance Sales by Region (2019-2024) & (K Units)
Table 41. South America New Psychoactive Substance Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa New Psychoactive Substance Sales by Region (2019-2024) & (K Units)
Table 43. Zynerba Pharmaceuticals New Psychoactive Substance Basic Information
Table 44. Zynerba Pharmaceuticals New Psychoactive Substance Product Overview
Table 45. Zynerba Pharmaceuticals New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Zynerba Pharmaceuticals Business Overview
Table 47. Zynerba Pharmaceuticals New Psychoactive Substance SWOT Analysis
Table 48. Zynerba Pharmaceuticals Recent Developments
Table 49. GW Pharmaceuticals New Psychoactive Substance Basic Information
Table 50. GW Pharmaceuticals New Psychoactive Substance Product Overview
Table 51. GW Pharmaceuticals New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GW Pharmaceuticals Business Overview
Table 53. GW Pharmaceuticals New Psychoactive Substance SWOT Analysis
Table 54. GW Pharmaceuticals Recent Developments
Table 55. Teewinot Life Sciences New Psychoactive Substance Basic Information
Table 56. Teewinot Life Sciences New Psychoactive Substance Product Overview
Table 57. Teewinot Life Sciences New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Teewinot Life Sciences New Psychoactive Substance SWOT Analysis
Table 59. Teewinot Life Sciences Business Overview
Table 60. Teewinot Life Sciences Recent Developments
Table 61. AusCann New Psychoactive Substance Basic Information
Table 62. AusCann New Psychoactive Substance Product Overview
Table 63. AusCann New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AusCann Business Overview
Table 65. AusCann Recent Developments
Table 66. Cannabics Pharmaceuticals New Psychoactive Substance Basic Information
Table 67. Cannabics Pharmaceuticals New Psychoactive Substance Product Overview
Table 68. Cannabics Pharmaceuticals New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cannabics Pharmaceuticals Business Overview
Table 70. Cannabics Pharmaceuticals Recent Developments
Table 71. Tilray New Psychoactive Substance Basic Information
Table 72. Tilray New Psychoactive Substance Product Overview
Table 73. Tilray New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Tilray Business Overview
Table 75. Tilray Recent Developments
Table 76. Cyrelian New Psychoactive Substance Basic Information
Table 77. Cyrelian New Psychoactive Substance Product Overview
Table 78. Cyrelian New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Cyrelian Business Overview
Table 80. Cyrelian Recent Developments
Table 81. Anandia Laboratories New Psychoactive Substance Basic Information
Table 82. Anandia Laboratories New Psychoactive Substance Product Overview
Table 83. Anandia Laboratories New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Anandia Laboratories Business Overview
Table 85. Anandia Laboratories Recent Developments
Table 86. InMed Pharmaceuticals New Psychoactive Substance Basic Information
Table 87. InMed Pharmaceuticals New Psychoactive Substance Product Overview
Table 88. InMed Pharmaceuticals New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. InMed Pharmaceuticals Business Overview
Table 90. InMed Pharmaceuticals Recent Developments
Table 91. Renew Biopharma New Psychoactive Substance Basic Information
Table 92. Renew Biopharma New Psychoactive Substance Product Overview
Table 93. Renew Biopharma New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Renew Biopharma Business Overview
Table 95. Renew Biopharma Recent Developments
Table 96. Cronos Group New Psychoactive Substance Basic Information
Table 97. Cronos Group New Psychoactive Substance Product Overview
Table 98. Cronos Group New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cronos Group Business Overview
Table 100. Cronos Group Recent Developments
Table 101. ICC International Cannabis New Psychoactive Substance Basic Information
Table 102. ICC International Cannabis New Psychoactive Substance Product Overview
Table 103. ICC International Cannabis New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. ICC International Cannabis Business Overview
Table 105. ICC International Cannabis Recent Developments
Table 106. Biotii Technologies New Psychoactive Substance Basic Information
Table 107. Biotii Technologies New Psychoactive Substance Product Overview
Table 108. Biotii Technologies New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Biotii Technologies Business Overview
Table 110. Biotii Technologies Recent Developments
Table 111. Global New Psychoactive Substance Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global New Psychoactive Substance Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America New Psychoactive Substance Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America New Psychoactive Substance Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe New Psychoactive Substance Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe New Psychoactive Substance Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific New Psychoactive Substance Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific New Psychoactive Substance Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America New Psychoactive Substance Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America New Psychoactive Substance Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa New Psychoactive Substance Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa New Psychoactive Substance Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global New Psychoactive Substance Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global New Psychoactive Substance Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global New Psychoactive Substance Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global New Psychoactive Substance Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global New Psychoactive Substance Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. New Psychoactive Substance Market Size Comparison by Region (M USD)
Table 5. Global New Psychoactive Substance Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global New Psychoactive Substance Sales Market Share by Manufacturers (2019-2024)
Table 7. Global New Psychoactive Substance Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global New Psychoactive Substance Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2022)
Table 10. Global Market New Psychoactive Substance Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers New Psychoactive Substance Sales Sites and Area Served
Table 12. Manufacturers New Psychoactive Substance Product Type
Table 13. Global New Psychoactive Substance Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of New Psychoactive Substance
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. New Psychoactive Substance Market Challenges
Table 22. Global New Psychoactive Substance Sales by Type (K Units)
Table 23. Global New Psychoactive Substance Market Size by Type (M USD)
Table 24. Global New Psychoactive Substance Sales (K Units) by Type (2019-2024)
Table 25. Global New Psychoactive Substance Sales Market Share by Type (2019-2024)
Table 26. Global New Psychoactive Substance Market Size (M USD) by Type (2019-2024)
Table 27. Global New Psychoactive Substance Market Size Share by Type (2019-2024)
Table 28. Global New Psychoactive Substance Price (USD/Unit) by Type (2019-2024)
Table 29. Global New Psychoactive Substance Sales (K Units) by Application
Table 30. Global New Psychoactive Substance Market Size by Application
Table 31. Global New Psychoactive Substance Sales by Application (2019-2024) & (K Units)
Table 32. Global New Psychoactive Substance Sales Market Share by Application (2019-2024)
Table 33. Global New Psychoactive Substance Sales by Application (2019-2024) & (M USD)
Table 34. Global New Psychoactive Substance Market Share by Application (2019-2024)
Table 35. Global New Psychoactive Substance Sales Growth Rate by Application (2019-2024)
Table 36. Global New Psychoactive Substance Sales by Region (2019-2024) & (K Units)
Table 37. Global New Psychoactive Substance Sales Market Share by Region (2019-2024)
Table 38. North America New Psychoactive Substance Sales by Country (2019-2024) & (K Units)
Table 39. Europe New Psychoactive Substance Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific New Psychoactive Substance Sales by Region (2019-2024) & (K Units)
Table 41. South America New Psychoactive Substance Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa New Psychoactive Substance Sales by Region (2019-2024) & (K Units)
Table 43. Zynerba Pharmaceuticals New Psychoactive Substance Basic Information
Table 44. Zynerba Pharmaceuticals New Psychoactive Substance Product Overview
Table 45. Zynerba Pharmaceuticals New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Zynerba Pharmaceuticals Business Overview
Table 47. Zynerba Pharmaceuticals New Psychoactive Substance SWOT Analysis
Table 48. Zynerba Pharmaceuticals Recent Developments
Table 49. GW Pharmaceuticals New Psychoactive Substance Basic Information
Table 50. GW Pharmaceuticals New Psychoactive Substance Product Overview
Table 51. GW Pharmaceuticals New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GW Pharmaceuticals Business Overview
Table 53. GW Pharmaceuticals New Psychoactive Substance SWOT Analysis
Table 54. GW Pharmaceuticals Recent Developments
Table 55. Teewinot Life Sciences New Psychoactive Substance Basic Information
Table 56. Teewinot Life Sciences New Psychoactive Substance Product Overview
Table 57. Teewinot Life Sciences New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Teewinot Life Sciences New Psychoactive Substance SWOT Analysis
Table 59. Teewinot Life Sciences Business Overview
Table 60. Teewinot Life Sciences Recent Developments
Table 61. AusCann New Psychoactive Substance Basic Information
Table 62. AusCann New Psychoactive Substance Product Overview
Table 63. AusCann New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AusCann Business Overview
Table 65. AusCann Recent Developments
Table 66. Cannabics Pharmaceuticals New Psychoactive Substance Basic Information
Table 67. Cannabics Pharmaceuticals New Psychoactive Substance Product Overview
Table 68. Cannabics Pharmaceuticals New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cannabics Pharmaceuticals Business Overview
Table 70. Cannabics Pharmaceuticals Recent Developments
Table 71. Tilray New Psychoactive Substance Basic Information
Table 72. Tilray New Psychoactive Substance Product Overview
Table 73. Tilray New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Tilray Business Overview
Table 75. Tilray Recent Developments
Table 76. Cyrelian New Psychoactive Substance Basic Information
Table 77. Cyrelian New Psychoactive Substance Product Overview
Table 78. Cyrelian New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Cyrelian Business Overview
Table 80. Cyrelian Recent Developments
Table 81. Anandia Laboratories New Psychoactive Substance Basic Information
Table 82. Anandia Laboratories New Psychoactive Substance Product Overview
Table 83. Anandia Laboratories New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Anandia Laboratories Business Overview
Table 85. Anandia Laboratories Recent Developments
Table 86. InMed Pharmaceuticals New Psychoactive Substance Basic Information
Table 87. InMed Pharmaceuticals New Psychoactive Substance Product Overview
Table 88. InMed Pharmaceuticals New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. InMed Pharmaceuticals Business Overview
Table 90. InMed Pharmaceuticals Recent Developments
Table 91. Renew Biopharma New Psychoactive Substance Basic Information
Table 92. Renew Biopharma New Psychoactive Substance Product Overview
Table 93. Renew Biopharma New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Renew Biopharma Business Overview
Table 95. Renew Biopharma Recent Developments
Table 96. Cronos Group New Psychoactive Substance Basic Information
Table 97. Cronos Group New Psychoactive Substance Product Overview
Table 98. Cronos Group New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cronos Group Business Overview
Table 100. Cronos Group Recent Developments
Table 101. ICC International Cannabis New Psychoactive Substance Basic Information
Table 102. ICC International Cannabis New Psychoactive Substance Product Overview
Table 103. ICC International Cannabis New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. ICC International Cannabis Business Overview
Table 105. ICC International Cannabis Recent Developments
Table 106. Biotii Technologies New Psychoactive Substance Basic Information
Table 107. Biotii Technologies New Psychoactive Substance Product Overview
Table 108. Biotii Technologies New Psychoactive Substance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Biotii Technologies Business Overview
Table 110. Biotii Technologies Recent Developments
Table 111. Global New Psychoactive Substance Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global New Psychoactive Substance Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America New Psychoactive Substance Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America New Psychoactive Substance Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe New Psychoactive Substance Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe New Psychoactive Substance Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific New Psychoactive Substance Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific New Psychoactive Substance Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America New Psychoactive Substance Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America New Psychoactive Substance Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa New Psychoactive Substance Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa New Psychoactive Substance Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global New Psychoactive Substance Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global New Psychoactive Substance Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global New Psychoactive Substance Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global New Psychoactive Substance Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global New Psychoactive Substance Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of New Psychoactive Substance
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global New Psychoactive Substance Market Size (M USD), 2019-2030
Figure 5. Global New Psychoactive Substance Market Size (M USD) (2019-2030)
Figure 6. Global New Psychoactive Substance Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. New Psychoactive Substance Market Size by Country (M USD)
Figure 11. New Psychoactive Substance Sales Share by Manufacturers in 2023
Figure 12. Global New Psychoactive Substance Revenue Share by Manufacturers in 2023
Figure 13. New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market New Psychoactive Substance Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by New Psychoactive Substance Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global New Psychoactive Substance Market Share by Type
Figure 18. Sales Market Share of New Psychoactive Substance by Type (2019-2024)
Figure 19. Sales Market Share of New Psychoactive Substance by Type in 2023
Figure 20. Market Size Share of New Psychoactive Substance by Type (2019-2024)
Figure 21. Market Size Market Share of New Psychoactive Substance by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global New Psychoactive Substance Market Share by Application
Figure 24. Global New Psychoactive Substance Sales Market Share by Application (2019-2024)
Figure 25. Global New Psychoactive Substance Sales Market Share by Application in 2023
Figure 26. Global New Psychoactive Substance Market Share by Application (2019-2024)
Figure 27. Global New Psychoactive Substance Market Share by Application in 2023
Figure 28. Global New Psychoactive Substance Sales Growth Rate by Application (2019-2024)
Figure 29. Global New Psychoactive Substance Sales Market Share by Region (2019-2024)
Figure 30. North America New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America New Psychoactive Substance Sales Market Share by Country in 2023
Figure 32. U.S. New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada New Psychoactive Substance Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico New Psychoactive Substance Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe New Psychoactive Substance Sales Market Share by Country in 2023
Figure 37. Germany New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific New Psychoactive Substance Sales and Growth Rate (K Units)
Figure 43. Asia Pacific New Psychoactive Substance Sales Market Share by Region in 2023
Figure 44. China New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America New Psychoactive Substance Sales and Growth Rate (K Units)
Figure 50. South America New Psychoactive Substance Sales Market Share by Country in 2023
Figure 51. Brazil New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa New Psychoactive Substance Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa New Psychoactive Substance Sales Market Share by Region in 2023
Figure 56. Saudi Arabia New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global New Psychoactive Substance Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global New Psychoactive Substance Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global New Psychoactive Substance Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global New Psychoactive Substance Market Share Forecast by Type (2025-2030)
Figure 65. Global New Psychoactive Substance Sales Forecast by Application (2025-2030)
Figure 66. Global New Psychoactive Substance Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of New Psychoactive Substance
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global New Psychoactive Substance Market Size (M USD), 2019-2030
Figure 5. Global New Psychoactive Substance Market Size (M USD) (2019-2030)
Figure 6. Global New Psychoactive Substance Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. New Psychoactive Substance Market Size by Country (M USD)
Figure 11. New Psychoactive Substance Sales Share by Manufacturers in 2023
Figure 12. Global New Psychoactive Substance Revenue Share by Manufacturers in 2023
Figure 13. New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market New Psychoactive Substance Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by New Psychoactive Substance Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global New Psychoactive Substance Market Share by Type
Figure 18. Sales Market Share of New Psychoactive Substance by Type (2019-2024)
Figure 19. Sales Market Share of New Psychoactive Substance by Type in 2023
Figure 20. Market Size Share of New Psychoactive Substance by Type (2019-2024)
Figure 21. Market Size Market Share of New Psychoactive Substance by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global New Psychoactive Substance Market Share by Application
Figure 24. Global New Psychoactive Substance Sales Market Share by Application (2019-2024)
Figure 25. Global New Psychoactive Substance Sales Market Share by Application in 2023
Figure 26. Global New Psychoactive Substance Market Share by Application (2019-2024)
Figure 27. Global New Psychoactive Substance Market Share by Application in 2023
Figure 28. Global New Psychoactive Substance Sales Growth Rate by Application (2019-2024)
Figure 29. Global New Psychoactive Substance Sales Market Share by Region (2019-2024)
Figure 30. North America New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America New Psychoactive Substance Sales Market Share by Country in 2023
Figure 32. U.S. New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada New Psychoactive Substance Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico New Psychoactive Substance Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe New Psychoactive Substance Sales Market Share by Country in 2023
Figure 37. Germany New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific New Psychoactive Substance Sales and Growth Rate (K Units)
Figure 43. Asia Pacific New Psychoactive Substance Sales Market Share by Region in 2023
Figure 44. China New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America New Psychoactive Substance Sales and Growth Rate (K Units)
Figure 50. South America New Psychoactive Substance Sales Market Share by Country in 2023
Figure 51. Brazil New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa New Psychoactive Substance Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa New Psychoactive Substance Sales Market Share by Region in 2023
Figure 56. Saudi Arabia New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa New Psychoactive Substance Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global New Psychoactive Substance Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global New Psychoactive Substance Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global New Psychoactive Substance Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global New Psychoactive Substance Market Share Forecast by Type (2025-2030)
Figure 65. Global New Psychoactive Substance Sales Forecast by Application (2025-2030)
Figure 66. Global New Psychoactive Substance Market Share Forecast by Application (2025-2030)
